Showing results (281-290 of 353) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2009
Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomniaHussien A Al-Shamma, Christen Anderson, Emil Chuang, et al.
Molecular Therapy. Nucleic Acids|October 15, 2018
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene KnockoutYvonne Knopp, Franziska K Geis, Dirk Heckl, et al.
Jac-Antimicrobial Resistance|August 6, 2024
Assessing antimicrobial stewardship governance in Northeast Brazilian hospitals: a survey-based analysisSylvia Lemos Hinrichsen, Marcela Coelho de Lemos, Juliana Magalhães Bernardino, et al.
Journal of Proteomics & Bioinformatics|October 7, 2014
A Proteomic Study of Human Merkel Cell CarcinomaQiang Shao, Stephanie D Byrum, Linley E Moreland, et al.
Addiction Biology|June 9, 2016
The antihypertensive drug pindolol attenuates long-term but not short-term binge-like ethanol consumption in miceOmkar L Patkar, Arnauld Belmer, Joan Y Holgate, et al.
Shock (Augusta, Ga.)|January 16, 2016
EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITYTrent M Woodruff, Mike C-L Wu, Michael Morgan, et al.
The EMBO Journal|October 4, 2021
CDKL5 kinase controls transcription-coupled responses to DNA damageTaran Khanam, Ivan Muñoz, Florian Weiland, et al.
The New England Journal of Medicine|May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemiaRichard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Pageof 36